TherapyTips
a-person-taking-ketamine

Could Ketamine Be The Solution To Chronic Depression?

Research shows how ketamine is shedding its infamous reputation and making a difference against treatment-resistant depression.

Mark Travers, Ph.D.

By Mark Travers, Ph.D.

April 16, 2024

Mark Travers, Ph.D., is the lead psychologist at Awake Therapy, responsible for new client intake and placement. Mark received his B.A. in psychology, magna cum laude, from Cornell University and his M.A. and Ph.D. from the University of Colorado Boulder. His academic research has been published in leading psychology journals and has been featured in The New York Times and The New Yorker, among other popular publications. He is a regular contributor for Forbes and Psychology Today, where he writes about psycho-educational topics such as happiness, relationships, personality, and life meaning. Click here to schedule an initial consultation with Mark or another member of the Awake Therapy team. Or, you can drop him a note here.

More recently, ketamine is being studied for its therapeutic effects beyond depression. A study published in Ibrain suggests that ketamine could be beneficial in treating post-traumatic stress disorder and depression in patients who have failed to respond to traditional treatments such as talk therapy and psychiatric medications. Animal research, clinical trials and case reports have shown significant reductions in PTSD-related symptoms and rapid antidepressant effects.

However, the same study also raises some concerns over the long-term efficacy and safety of the drug, particularly in light of its effects on the nervous system.

Another recent article published in Missouri Medicine explores the availability of unsupervised and unregulated ketamine treatment through online for-profit companies. The review discusses the dangers of patients self-administering ketamine at home, particularly in the absence of proper medical supervision.

While ketamine's potential as a treatment for mental illness is undeniable and public interest in alternative therapies for certain conditions is evident, it's crucial to use caution and evidence-based practices in ensuring patient safety and wellness.

One mental health company that addresses the demand for novel treatments in treatment-resistant depression and other mental health conditions is Being Health. I spoke to Dr. Allie Sharma, co-founder and chief medical officer at the New York City-based company, to gain perspective on what is involved in ketamine infusion therapy and why it is likely to lead a change in how we approach the mental health of those who find traditional methods of treatment ineffective. Here are two important things I learned from our conversation.

1. There Are Safety Protocols And A Stringent Screening Process For Ketamine Infusion Therapy

"Treatment-resistant depression is defined as at least two failed medication trials of antidepressants for the current episode of depression," Sharma explains. "We offer Ketamine Infusion Therapy for treatment-resistant depression, given that Ketamine has been shown in numerous studies to provide rapid improvement and durability of response and has the potential to make a long-lasting impact in people's lives by alleviating the symptoms of depression."

Being Health's ketamine-based treatment was developed over the course of nearly two years with experts in the fields of anesthesiology and psychiatry. It unfolds through a structured, five-step process designed to ensure the safety, effectiveness and personalized care for each patient undergoing ketamine infusion therapy. Here's a breakdown of the process:

This procedural approach ensures that individuals at risk or unlikely to benefit from ketamine are carefully screened out, prioritizing patient safety and the effectiveness of the treatment.

2. Ensuring Fair And Safe Access To Ketamine-Based Treatments Is Important

A 2022 narrative review published in the Journal of Pain Research points to ketamine's beneficial and significant role in reducing symptoms of depression, both initially and over time. Interestingly, it was also found to have improved the psychotherapist-patient relationship, significantly enhancing treatment outcomes.

"KAP refers to a psychotherapy session conducted by a KAP therapist outside—not during or immediately after—the infusion. Therefore, the potential for ethical issues to arise during our KAP sessions is minimized since patients are not in an altered state of consciousness during the KAP sessions."

This measured approach to therapy involving ketamine is vital as it ensures that therapeutic benefits are maximized while maintaining the highest standards of patient safety and ethical treatment practices.

A commitment to safety, through rigorous protocols and expert-led care, exemplifies the responsible advancement in this field. As research continues, particularly in areas like PTSD and alcohol use disorder, and as other novel substances such as MDMA and psilocybin enter clinical trials, regulations are expected to evolve to ensure these therapies' safe and ethical use. This dynamic interplay between innovation and regulation underscores a hopeful direction for mental health treatment, promising more effective solutions for those grappling with persistent mental health challenges.

A similar version of this article can also be found on Forbes.com,here, and on PsychologyToday.com, here.